FindTrial
Sign In

Impact of premature LH increase on women with normal response undergoing IVF-ET using GnRH antagonist protocol: a randomized controlled clinical trial

Effect of premature LH increase among women with normal response undergoing IVF-ET using GnRH antagonist protocol

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800018521
Enrollment
Unknown
Registered
2018-09-21
Start date
2018-10-01
Completion date
Unknown
Last updated
2018-09-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertility

Interventions

group 1:fresh embryo transfer
group 1:frozen embryo transfer

Sponsors

Beijing Chao-Yang Hospital affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Women aged 23-35 years; 2. Regular menstrual cycle of 21-35 days; 3. basal FSH<10IU/L, AFC 8-20; 4. BMI18-25kg/m2; 5. The subjects must be volunteers and sign informed consents in person or by the legal representative.

Exclusion criteria

Exclusion criteria: 1. Polycystic ovarian syndrome, hyperprolactinemia; 2. ultrasound or hysteroscopy indicated intrauterine or endometrial lesion, including uterine malformation, endometrial polyp, hyperplasia, intrauterine adhesion, etc; 3. endometriosis, adenomyosis; 4. medical comorbidities like diabetes mellitus, hyperthyreosis.

Design outcomes

Primary

MeasureTime frame
implantation rate;—

Secondary

MeasureTime frame
ongoing pregnancy rate;clinical pregnancy rate;—

Countries

China

Contacts

Public ContactYuan Li

Beijing Chao-Yang Hospital affiliated to Capital Medical University

sduly@126.com+86 010 85231423

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026